Prostate artery embolization using n-butyl cyanoacrylate glue for symptomatic benign prostatic hyperplasia: A six-month outcome analysis in 103 patients.

Date publication

décembre 2023

Journal

Diagnostic and interventional imaging

Auteurs

Membres identifiés du Cancéropôle Est :
Pr LOFFROY Romaric

Tous les auteurs :
Loffroy R, Quirantes A, Guillen K, Mazit A, Comby PO, Aho-Glélé LS, Chevallier O

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/38161141

Résumé

The purpose of this study was to assess the feasibility, safety, and 6-month outcomes of prostate artery embolization (PAE) using N-butyl-cyanoacrylate (NBCA) glue as the only embolic agent in patients with benign prostatic hyperplasia (BPH)-related lower urinary tract symptoms.

Mots clés

Benign prostate hyperplasia, Cyanoacrylates, Lower urinary tract symptoms, Outcome studies, Prostate artery embolization

Référence

Diagn Interv Imaging. 2023 12 30;: